Relationship of Pain Catastrophizing With Urinary Biomarkers in Women With Bladder Pain Syndrome.
Relationship of Pain Catastrophizing With Urinary Biomarkers in Women With Bladder Pain Syndrome.
复制标题
DOI:
10.1097/spv.0000000000001041
复制
发表时间:
2021-12-01
影响因子:
1.6
通讯作者:
Arya L
中科院分区:
文献类型:
--
作者:
Soriano A;Allen A;Malykhina AP;Andy U;Harvie H;Arya L
Brain-derived neurotrophic factor (BDNF) has been implicated in central neurological processes. We hypothesize that greater pain catastrophizing is associated with higher urinary BDNF levels in women with bladder pain syndrome. Secondary analysis of a database of women with urinary urgency. We identified women who met AUA criteria of bladder pain syndrome. Urinary symptoms, pain catastrophizing, and neuropathic pain were measured using the Female Genitourinary Pain Index (F-GUPI), Pain Catastrophizing Scale (PCS) and painDETECT questionnaires respectively. Relationship of catastrophizing score with urinary BDNF (primary outcome) and other urinary biomarkers including nerve growth factor (NGF), vascular endothelial growth factor (VEGF) and osteopontin was evaluated using univariable and multivariable analyses. In 62 women with bladder pain syndrome, 15 (24%) reported pain catastrophizing symptoms (PCS score >30). Higher catastrophizing scores were associated with worse urinary symptoms, greater pelvic pain, greater neuropathic pain, and worse quality of life scores (all p<0.01). On multivariable analysis, after controlling for age, BMI and urinary symptoms, higher pain catastrophizing score was associated with lower BDNF (p=0.04) and lower VEGF levels (p=0.03). Urinary urgency was associated with higher NGF level (p=0.04) while bladder pain was associated with higher levels of NGF (p=0.03) and VEGF (p=0.01). Neuroinflammatory mechanisms contribute to the central processing of pain in women with bladder pain syndrome. Worse urinary symptoms are associated with higher NGF and VEGF levels, but worse pain catastrophizing is associated with lower BDNF and VEGF levels. Urinary BDNF levels may be useful in phenotyping women who have central augmentation of pain processing.